Merck’s antiviral shows promise, the global death toll hits a grim milestone, and researchers look at universal coronavirus vaccines— Tech in Two
Nov 2, 2021
02:19
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt